Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.080
+0.105 (10.78%)
Jun 3, 2025, 11:33 AM - Market open
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $100.44 million as of June 3, 2025. Its market cap has decreased by -69.45% in one year.
Market Cap
100.44M
Enterprise Value
-85.78M
1-Year Change
-69.45%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $100.44M, a decrease of -88.69%. That is a compound annual growth rate of -43.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 98.58M | -31.53% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |